IVVD

Invivyd

2.35

0.58+32.77%

After Hours: 2.320 -0.03 -1.26%19:59 11/14 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.560/1.770

TODAY RANGE2.160-2.760

VOL136.45M

MARKET CAP547.84M

52 WEEK RANGE0.3546-2.760

AVG VOL (3M)9.96M

% TURNOVER58.53%

TURNOVER--

P/E (TTM)-4.9620

% RANGE33.90%

EPS(TTM)-0.4736

P/E(FORWARD)-5.4023

P/B5.41

BVPS0.4341

DIVIDEND--

P/S11.10

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP460.36M

SHARES OUTSTANDING233.12M

NEXT EARNINGS--

FREE FLOAT195.90M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·23h ago
BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, GE Vernova, Walmart
NASDAQ·1d ago
Friday Sector Leaders: Oil & Gas Refining & Marketing, Biotechnology Stocks
NASDAQ·1d ago
Pre-Market Most Active for Nov 14, 2025 : IVVD, TSLL, SQQQ, IBIT, IONZ, NVDA, NIO, QBTS, BBAI, IONQ, CRCL, TE
TipRanks·11/07 16:05
Invivyd’s Strategic Advancements and Strong Financial Position Justify Buy Rating
TipRanks·11/07 15:07
Cantor Fitzgerald Keeps Their Buy Rating on Invivyd (IVVD)
TipRanks·11/07 05:49
Invivyd Reports Strong Q3 Growth and Strategic Advances
TipRanks·11/07 01:27
Invivyd’s Earnings Call: Positive Outlook Amid Challenges
TipRanks·11/06 12:32
Invivyd Reports Strong Q3 Growth and FDA Clearance
Reuters·11/06 12:27
Invivyd Q3 net loss beats estimates on higher PEMGARDA sales among healthcare providers
Reuters·11/06 12:11
Invivyd Inc. reports Q3 net product revenue of $13.1 million
Reuters·11/06 12:03
Invivyd Appoints Paul B. Bolno to Board and Kristie Kuhl as Chief Communications Officer
Dow Jones·11/06 12:01
Press Release: Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
NASDAQ·11/05 12:40
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
NASDAQ·11/04 15:00
Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Dow Jones·11/03 12:25
Invivyd Price Target Raised to $10.00/Share From $5.00 by HC Wainwright & Co.

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.49%

842.09

Biogen Inc

BIIB

+1.71%

167.55

Amgen Inc

AMGN

+0.22%

336.74

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-0.33%

0.0299

Lilly Eli & Co

LLY

+0.38%

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+20.99%

1.96

Johnson & Johnson

JNJ

+0.35%

195.93

Abbvie Inc

ABBV

+0.03%

232.36

Zoetis Inc

ZTS

-0.28%

120.82

Gilead Sciences Inc

GILD

-0.14%

125.02

Novo-Nordisk A/S

NVO

-1.83%

48.26

Bristol-Myers Squibb Co

BMY

-4.07%

46.65

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-2.83%

25.06

Sanofi FR

SNY

-0.38%

52.14

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.49%

131.26

Dr Reddys Labs

RDY

+0.50%

13.94

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.